Onconova Therapeutics (ONTX) Tops Q2 EPS by 11c, misses on revenue

Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($0.20), $0.11 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $69.25 thousand.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c